Covance Is Now Labcorp Drug Development

We are one global company innovating for millions – together, continuing to bring you more advanced medical breakthroughs.

Learn More

SERVICES

Clinical Trial Laboratory Services

Comprehensive laboratory support for all phases of clinical trials.

Contact Us

Trending Topics

Video

The Modulatory Effects of a PI3Kδ Specific Small Molecule Inhibitor (IOA-244) on Basophil Degranulation Measured by Flow Cytometry

During this short 8-minute presentation, our staff scientist Eirini Kamileri, PhD evaluates the performance of the IOA-244 drug (a selective PI3Kδ inhibitor), on IgE-induced basophilic activation, through flow cytometry.

Video

Validation of CLL ERIC MRD Flow Cytometry Panel in a CAP/CLIA-Compliant Model

During this short 11-minute video, our staff scientist Marc Campillos, PhD discusses validation for the CLL ERIC MRD flow cytometry assay in a CAP/CLIA-compliant model to confirm performance of the assay in terms of precision, sensitivity and stability, while including run pass fail criteria using QC reagents.

Webinar

Supporting CAR T-Cell Development with a Translational Biomarker Strategy

Biomarkers play a critical part in accelerating CAR T-cell development. This 25-minute session, delves into the importance of a translational biomarker strategy in assessing safety and efficacy to navigate regulatory pathways in rapid development of CAR T-cell therapies.

Whitepaper

De-Risk and Streamline Your Drug Substance & Drug Product Testing

The development of a new biologic requires effective management of time and risk. The drug manufacturing process will progress in scale and likely location for both drug substance and drug product.

Webinar

Challenges & Best Practices in Supporting Clinical Bioanalysis in China

In this on-demand webinar, learn more about the key considerations and best practices for supporting your global clinical trial with regulated bioanalysis in China. Topics covered include: special requirements for China submission studies, differences in global quality standards and technical expertise, resourcing and customs challenges in China, and advanced technologies for supporting existing and emerging modalities.

Info Sheet

Testing Solutions to Advance Your COVID-19 Clinical Trials

Developing a vaccine or therapeutic in response to the outbreak of the 2019 Novel Coronavirus (COVID-19) requires a laboratory with significant technical and cross-functional experience. Our Central Laboratories are prepared to support your COVID-19 studies.

Featured Video

Propel Your Biomarker Strategy

PhD-level leaders within our Biomarker Solution Center can provide specialized therapeutic area expertise to create a successful biomarker strategy for your next study.

Clinical Testing Services for Drug Development

Biomarker-driven trial design and testing add complexity to the drug development process, with laboratory support required at every phase. 

We are committed to helping you navigate the process, providing comprehensive scientific and medical support to complement your drug development program.

TESTIMONIAL

“Patient care is always top of mind for our clinical trial laboratory services. Thinking about how tests can positively impact patient lives drives us to continually strive to be first to innovation.”

Patrick Hastings
Global Vice President and Head of Central Laboratory Services

Educational Insights

Overcoming Bottlenecks in Quantifying Oligonucleotide Therapeutics

Overcoming Bottlenecks in Quantifying Oligonucleotide Therapeutics

Articles
Overcoming Bottlenecks in Quantifying Oligonucleotide Therapeutics: Using LC-MS/MS Technology and Expertise to Reduce Risk and Increase Your Speed to Market Developing bioanalytical solutions to support oligonucleotide drug programs can be challenging due to the unique physicochemical properties of these molecules. This whitepaper outlines both the established and the unique liquid chromatography and extraction technologies we have developed to ensure you remain at the forefront of oligonucleotide innovation. Learn how you can benefit from the workflows to: eliminate bottlenecks and accelerate timelines with state-of-the-art liquid chromatography, focused detection and extraction technologies that generate accurate and robust data, rapidly receive the results you need through world-class scientific expertise based on decades of experience in solving complex bioanalytical challenges and capitalize on the rapidly expanding oligonucleotide marketing with the support of technologies and expertise.
Read More
Empowering Development and Enabling Seamless Assay Transfer

Empowering Development and Enabling Seamless Assay Transfer

Articles
Exploratory and preclinical studies often require rapid development of assays. In creating novel immunoassays or providing cellular-based analysis, researchers must proactively plan for a transition to CAP/CLIA or GxP facility for qualification, method validation and implementation. These case studies showcase a number of challenging, high-profile projects supported by the Labcorp Drug Development Translational Biomarker Solutions (Labcorp Drug Development TBS) team.
Read More
Challenges and Best Practices in Supporting Clinical Bioanalysis in China

Challenges and Best Practices in Supporting Clinical Bioanalysis in China

Articles
In the rapidly evolving Chinese research and development (R&D) landscape, there are several key considerations for effectively supporting global clinical trials with regulated bioanalysis in China. This white paper discusses the current status of bioanalysis in the region, in-country support and local guidance strategies to combat potential challenges in supporting clinical bioanalysis within China.
Read More
Trends in Immuno-Oncology from Preclinical Models Through Biomarkers and Clinical Trial Design

Trends in Immuno-Oncology from Preclinical Models Through Biomarkers and Clinical Trial Design

Videos & Webinars
Learn from three thought leaders in the field of immunotherapy as they share their knowledge on trends and advances across the entire spectrum of development.
Read More

Let us know about your interests and one of our specialists will contact you directly.

SPEAK WITH A SPECIALIST

Contact Us